| Literature DB >> 31252518 |
Liming Zhao1, Barry W Alto2, Yongxing Jiang3, Fahong Yu4, Yanping Zhang4.
Abstract
Aedes aegypti (L.) is the primary vector of emergent mosquito-borne viruses, including chikungunya, dengue, yellow fever, and Zika viruses. To understand how these viruses interact with their mosquito vectors, an analysis of the innate immune system response was conducted. The innate immune system is a conserved evolutionary defense strategy and is the dominant immune system response found in invertebrates and vertebrates, as well as plants. RNA-sequencing analysis was performed to compare target transcriptomes of two Florida Ae. aegypti strains in response to chikungunya virus infection. We analyzed a strain collected from a field population in Key West, Florida, and a laboratory strain originating from Orlando. A total of 1835 transcripts were significantly expressed at different levels between the two Florida strains of Ae. aegypti. Gene Ontology analysis placed these genes into 12 categories of biological processes, including 856 transcripts (up/down regulated) with more than 1.8-fold (p-adj (p-adjust value) ≤ 0.01). Transcriptomic analysis and q-PCR data indicated that the members of the AaeCECH genes are important for chikungunya infection response in Ae. aegypti. These immune-related enzymes that the chikungunya virus infection induces may inform molecular-based strategies for interruption of arbovirus transmission by mosquitoes.Entities:
Keywords: Aedes aegypti; anti-microbial peptide; chikungunya virus; gene expression; immune responses; transcriptome
Year: 2019 PMID: 31252518 PMCID: PMC6651163 DOI: 10.3390/ijms20133133
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Chikungunya virus (CHIKV) titers (log10 pfu/mL) (Least Squares means ± Standard Error) in infectious blood meals and mosquitoes of the Key West and Orlando strains of Aedes aegypti. Titers followed by the same letter are not significantly different from one another. Comparisons of time points are presented only for Key West (lower case letters) and Orlando (upper case letters) strains.
| Strains | Initial Dose in Bloodmeal | Freshly Fed | 1 Day Post Infection | 2 Days Post Infection | 5 Days Post Infection | 7 Days Post Infection | 10 Days Post Infection |
|---|---|---|---|---|---|---|---|
|
| 8.0 ± 0.09 | 4.89 ± 0.39 | 3.79 ± 0.23 a | 4.47 ± 0.32 ab | 5.87 ± 0.39 bc | 5.83 ± 0.39 bc | 4.96 ± 0.39 ab |
|
| 8.3 ± 0.08 | 5.68 ± 0.39 | 3.09 ± 0.23 A | 1.70 ± 0.30 B | 4.78 ± 0.39 C | 4.02 ± 0.32 AC | 4.24 ± 0.39 AC |
CHIKV (La Réunion strain LR2006-OPY1, GenBank KT449801) from a human infected on La Réunion Island in 2006 [50]. Primers: CHIKV-FWD: 5′GTACGGAAGGTAAACTGGTATGG-3’; CHIKV-REV: 5′-TCCACCTCCCACTCCTTAAT-3′.
Figure 1Overview of the functional categories of differentially expressed (DE) transcripts in response to CHIKV infection. DE genes were determined based on statistical analysis by DESeq package. The total number of DE genes for each comparison is shown in parentheses in each figure. Gene Ontology (GO) analysis of DE genes was performed based on the database of AmiGO 2. Up, upregulated DE genes; Down, downregulated DE genes. (A) 3 h post infection KW-CHIKV compared with KW-Control, A1 Up and A2 Down; (B) 3-day post infection, KW-CHIKV compared with KW-Control, B1 Up and B2 Down; (C) 3 days post infection, KW-Control compared with OR-Control, C1 Up and C2 Down; (D) 3 days post infection, KW-CHIKV compared with OR-CHIKV, D1 Up and D2 Down; (E) 3 days post infection, E1: OR-CHIKV compared with OR-Control, E1 UP; OR-CHIKV compared with OR-Control 339 gene down regulated with p-adj ≤ 0.01, only three genes were detected in the GO, which are not shown in the figure.
Immune-related genes that were significantly regulated in the Key West strain of Aedes aegypti 3 h post infection with CHIKV compared with Control in Key West strain (p-adj ≤ 0.01, log2-fold change ≥ ± 1.8).
| Transcript ID | Log2 FC | Gene Description | |
|---|---|---|---|
| AAEL004199-RA | −1.9388 | 3.4 × 10−4 | allergen |
| AAEL003057-RB | 2.8963 | 4.2 × 10−6 | allergen |
| AAEL014658-RA | 2.2755 | 4.4 × 10−4 | caspase-1 protein |
| AAEL000621-RA | 2.2216 | 3.4 × 10−4 | cecropin anti-microbial peptide |
| AAEL005374-RA | −3.2830 | 1.1 × 10−27 | Class B Scavenger Receptor (CD36 domain) |
| AAEL005979-RA | −2.0366 | 1.9 × 10−4 | Class B Scavenger Receptor (CD36 domain) |
| AAEL005981-RA | −1.8895 | 1.5 × 10−5 | Class B Scavenger Receptor (CD36 domain) |
| AAEL000234-RA | 1.8135 | 1.6 × 10−4 | Class B Scavenger Receptor (CD36 domain) |
| AAEL009432-RA | 4.0915 | 3.5 × 10−12 | Class B Scavenger Receptor (CD36 domain) |
| AAEL001098-RA | −2.2546 | 2.9 × 10−7 | Clip-Domain Serine Protease |
| AAEL014137-RA | −2.3522 | 3.2 × 10−7 | Clip-Domain Serine Protease family B |
| AAEL008668-RA | 1.8083 | 1.8 × 10−3 | Clip-Domain Serine Protease family B |
| AAEL000760-RA | 2.2343 | 4.1 × 10−5 | Clip-Domain Serine Protease family B |
| AAEL005648-RA | −1.9389 | 2.0 × 10−3 | Clip-Domain Serine Protease family B |
| AAEL005792-RA | −2.0842 | 5.1 × 10−4 | Clip-Domain Serine Protease family E |
| AAEL001077-RA | −1.9692 | 6.8 × 10−13 | Clip-Domain Serine Protease family B |
| AAEL008299-RA | −2.4009 | 7.4 × 10−5 | C-Type Lectin (CTL) |
| AAEL004679-RA | −2.0008 | 5.5 × 10−3 | C-Type Lectin (CTL) |
| AAEL000533-RA | 2.0222 | 1.9 × 10−4 | C-Type Lectin (CTL) |
| AAEL000556-RA | 3.3807 | 2.4 × 10−28 | C-Type Lectin (CTL) |
| AAEL011078-RA | −2.5784 | 1.9 × 10−3 | C-Type Lectin (CTL)—galactose binding |
| AAEL011455-RA | 2.3166 | 2.9 × 10−4 | C-Type Lectin (CTL)—mannose binding |
| AAEL009384-RA | −1.9456 | 3.7 × 10−7 | fibrinogen and fibronectin |
| AAEL000726-RA | 3.6985 | 4.1 × 10−42 | fibrinogen and fibronectin |
| AAEL003894-RA | −1.8649 | 3.0 × 10−3 | Gram-Negative Binding Protein (GNBP) |
| AAEL003966-RA | −1.9430 | 2.8 × 10−6 | lachesin |
| AAEL010125-RA | 2.3599 | 8.2 × 10−10 | leucine-rich immune protein (Coil-less) |
| AAEL010132-RA | 2.4747 | 2.5 × 10−5 | leucine-rich immune protein (Long) |
| AAEL012255-RA | 1.8045 | 7.8 × 10−4 | leucine-rich immune protein (Short) |
| AAEL001420-RA | 1.9602 | 5.0 × 10−10 | leucine-rich immune protein (Short) |
| AAEL001401-RA | 2.0463 | 3.8 × 10−18 | leucine-rich immune protein (Short) |
| AAEL010772-RA | −2.2935 | 3.6 × 10−6 | leucine-rich repeat-containing protein |
| AAEL011760-RA | −2.2672 | 9.7 × 10−4 | leucine-rich transmembrane protein |
| AAEL012093-RA | 2.0559 | 2.0 × 10−4 | leucine-rich transmembrane protein |
| AAEL008271-RA | 6.5329 | 4.5 × 10−12 | SEC14, putative protein |
| AAEL007432-RA | 6.4799 | 1.5 × 10−65 | serine collagenase 1 precursor |
| AAEL002510−RB | 1.8323 | 1.4 × 10−4 | serine hydro×ymethyltransferase |
| AAEL000224-RA | −3.2320 | 2.1 × 10−3 | serine protease |
| AAEL013427-RA | −3.1475 | 4.8 × 10−4 | serine protease |
| AAEL007106-RA | 2.1779 | 2.0 × 10−4 | serine protease |
| AAEL002704-RB | 3.1322 | 3.4 × 10−37 | Serine Protease Inhibitor (serpin) |
| AAEL002731-RA | 2.1521 | 2.7 × 10−10 | Serine Protease Inhibitor (serpin) |
| AAEL007420-RB | 3.3676 | 6.7 × 10−23 | Serine Protease Inhibitor (serpin) |
| AAEL003182-RA | 3.5677 | 2.1 × 10−43 | Serine Protease Inhibitor (serpin) |
| AAEL011891-RA | 2.7316 | 6.5 × 10−3 | serine-type endopeptidase |
| AAEL006902-RA | 3.1972 | 6.8 × 10−6 | serine-type endopeptidase |
| AAEL008567-RA | 3.5171 | 5.4 × 10−13 | serine-type endopeptidase |
| AAEL001703-RA | 3.7862 | 2.8 × 10−8 | serine-type endopeptidase |
| AAEL008784-RA | 3.9399 | 6.6 × 10−6 | serine-type endopeptidase |
| AAEL001674-RA | 5.4452 | 6.4 × 10−6 | serine-type endopeptidase |
| AAEL014188-RA | 5.5757 | 1.8 × 10−9 | serine-type endopeptidase |
| AAEL009843-RA | 5.7334 | 2.4 × 10−59 | serine-type endopeptidase |
| AAEL013284-RA | 5.8404 | 1.4 × 10−8 | serine-type endopeptidase |
| AAEL003060-RA | 6.2886 | 7.2 × 10−129 | serine-type endopeptidase |
| AAEL001693-RA | 7.8599 | 1.2 × 10−109 | serine-type endopeptidase |
| AAEL001690-RA | 8.1855 | 7.1 × 10−114 | serine-type endopeptidase |
| AAEL008236-RA | −2.6394 | 9.4 × 10−3 | sidestep protein |
| AAEL000398-RA | −2.4779 | 4.8 × 10−3 | sidestep protein |
| AAEL009943-RA | −2.2813 | 5.3 × 10−5 | sidestep protein |
| AAEL010645-RA | 3.8037 | 9.9 × 10−3 | sidestep protein |
| AAEL011989-RB | 1.9061 | 4.9 × 10−10 | signal peptide peptidase |
| AAEL014755-RA | −2.4382 | 1.7 × 10−3 | tep2 protein |
| AAEL008607-RA | −1.8312 | 4.5 × 10−10 | tep3 protein |
| AAEL015018-RA | 2.2916 | 6.7 × 10−4 | toll protein |
| AAEL004000-RA | −2.9297 | 5.8 × 10−4 | Toll-like receptor |
| AAEL009551-RA | −2.8670 | 1.4 × 10−3 | Toll-like receptor |
| AAEL012780-RA | −5.2801 | 3.1 × 10−3 | trypsin |
| AAEL006414-RA | −2.6981 | 1.7 × 10−7 | trypsin |
| AAEL006430-RA | −2.6562 | 2.2 × 10−3 | trypsin |
| AAEL006429-RA | −2.4442 | 3.8 × 10−5 | trypsin |
| AAEL005764-RA | −2.1564 | 7.9 × 10−16 | trypsin |
| AAEL010202-RA | 1.9991 | 2.3 × 10−3 | trypsin |
| AAEL008093-RA | 2.6642 | 1.1 × 10−7 | trypsin |
| AAEL008085-RA | 4.4810 | 5.5 × 10−27 | trypsin |
| AAEL013703-RA | 5.2463 | 1.2 × 10−72 | trypsin |
| AAEL006425-RA | 5.2958 | 2.4 × 10−19 | trypsin |
| AAEL013715-RA | 8.8303 | 1.9 × 10−42 | trypsin |
| AAEL007601-RA | 9.5930 | 1.2 × 10−90 | trypsin |
| AAEL013707-RA | 9.8853 | 1.9 × 10−50 | trypsin |
| AAEL013714-RA | 10.627 | 4.3 × 10−48 | trypsin |
| AAEL010196-RA | 10.743 | 1.5 × 10−36 | trypsin |
| AAEL007818-RB | 2.8577 | 9.9 × 10−7 | Trypsin 3A1 Precursor |
| AAEL013712-RA | 6.7673 | 1.2 × 10−24 | Trypsin 5G1 Precursor |
| AAEL013629-RA | 3.3504 | 2.1 × 10−13 | trypsin-alpha |
| AAEL008079-RA | 6.2776 | 1.7 × 10−16 | trypsin-alpha |
| AAEL006403-RA | −3.7628 | 4.8 × 10−10 | trypsin-beta |
| AAEL008080-RA | 2.3952 | 1.2 × 10−5 | trypsin-eta |
| AAEL013628-RA | 4.8704 | 4.2 × 10−14 | trypsin-eta |
| AAEL000793-RA | 3.3944 | 1.1 × 10−48 | venom allergen |
Immune-related genes that were significantly regulated in the Key West strain of Aedes aegypti 3 days post ingestion with CHIKV compared with Control in Key West strain (p-adj ≤ 0.01, log2-fold change ≥ ± 1.8).
| Transcript ID | Log2 FC | Gene Description | |
|---|---|---|---|
| AAEL004223-RA | 1.8947 | 1.1 × 10−6 | cecropin anti-microbial peptide |
| AAEL000037-RA | 3.0672 | 1.4 × 10−3 | Clip-Domain Serine Protease family B |
| AAEL006161-RB | 3.1447 | 1.1 × 10−3 | Clip-Domain Serine Protease family B |
| AAEL003632-RA | 3.0778 | 6.0 × 10−3 | Clip-Domain Serine Protease family B |
| AAEL005641-RA | 3.2355 | 4.9 × 10−4 | C-Type Lectin (CTL)—galactose binding |
| AAEL011455-RA | 4.1030 | 4.2 × 10−3 | C-Type Lectin (CTL)—mannose binding |
| AAEL012353-RA | 4.3829 | 1.3 × 10−3 | C-Type Lectin (CTL) |
| AAEL003857-RA | 7.3899 | 4.1 × 10−6 | defensin anti-microbial peptide |
| AAEL006691-RA | 1.9004 | 8.2 × 10−3 | fibrinogen and fibronectin |
| AAEL001401-RA | 2.7153 | 3.9 × 10−4 | leucine-rich immune protein (Short) |
| AAEL005734-RA | −1.9928 | 2.9 × 10−14 | leucine-rich transmembrane protein |
| AAEL002295-RA | 2.2469 | 6.8 × 10−3 | leucine-rich transmembrane protein |
| AAEL003597-RB | 2.4398 | 1.6 × 10−3 | leucine-rich transmembrane protein |
| AAEL005844-RA | −2.2151 | 9.8 × 10−25 | posF21, putative protein |
| AAEL008271-RA | 3.0341 | 8.6 × 10−3 | SEC14 putative protein |
| AAEL003896-RA | −1.7801 | 2.4 × 10−27 | serine/threonine protein kinase |
| AAEL009244-RA | 1.8418 | 2.3 × 10−7 | serine-type endopeptidase |
| AAEL001703-RA | 2.0534 | 2.9 × 10−4 | serine-type endopeptidase |
| AAEL009843-RA | 2.8570 | 8.1 × 10−3 | serine-type endopeptidase |
| AAEL003060-RA | 2.3460 | 1.1 × 10−5 | serine-type endopeptidase |
| AAEL007818-RB | 2.5953 | 7.1 × 10−4 | Trypsin 3A1 Precursor |
| AAEL006425-RA | 2.3896 | 3.0 × 10−9 | trypsin |
| AAEL013703-RA | 2.5507 | 3.3 × 10−4 | trypsin |
| AAEL008080-RA | 2.7631 | 2.1 × 10−4 | trypsin-eta |
| AAEL012473-RB | −2.1156 | 9.4 × 10−6 | vav1 protein |
Immunity-related genes significantly regulated in the Orlando strain Aedes aegypti 3 days post infection with CHIKV compared with Control in Orlando strain (p-adj ≤ 0.01, log2-fold change ≥ ± 1.8).
| Transcript ID | Log2 FC | Gene Description | |
|---|---|---|---|
| AAEL004223-RA | 2.3577 | 4.4 × 10−5 | cecropin anti-microbial peptide |
| AAEL017211-RA | 2.3359 | 3.3 × 10−4 | cecropin anti-microbial peptide |
| AAEL009680-RB | 4.7006 | 1.6 × 10−10 | chymotrypsin |
| AAEL000556-RA | 4.0712 | 6.3 × 10−6 | C-Type Lectin (CTL) |
| AAEL000533-RA | 3.0535 | 9.0 × 10−4 | C-Type Lectin (CTL) |
| AAEL009670-RA | 3.6210 | 1.3 × 10−3 | C-Type Lysozyme (Lys-D) |
| AAEL003849-RA | 3.1292 | 4.3 × 10−3 | defensin anti-microbial peptide |
| AAEL000726-RA | 4.7815 | 5.9 × 10−8 | fibrinogen and fibronectin |
| AAEL006691-RA | 3.2048 | 2.7 × 10−6 | fibrinogen and fibronectin |
| AAEL007942-RA | 3.4734 | 7.6 × 10−6 | fibrinogen and fibronectin |
| AAEL011007-RA | 4.5979 | 1.0 × 10−6 | fibrinogen and fibronectin |
| AAEL004522-RA | 3.1695 | 2.6 × 10−3 | gambicin anti-microbial peptide |
| AAEL012092-RA | 2.0567 | 8.4 × 10−3 | leucine-rich repeat |
| AAEL002295-RA | 2.6054 | 1.3 × 10−4 | leucine-rich transmembrane protein |
| AAEL007420-RB | 5.1106 | 2.4 × 10−5 | Serine Protease Inhibitor (serpin) |
| AAEL003182-RA | 4.6609 | 7.4 × 10−4 | Serine Protease Inhibitor (serpin) |
| AAEL002704-RB | 4.2747 | 1.5 × 10−3 | Serine Protease Inhibitor (serpin) |
| AAEL006902-RA | 3.6563 | 3.6 × 10−6 | serine-type endopeptidase |
| AAEL008567-RA | 3.1476 | 7.6 × 10−9 | serine-type endopeptidase |
| AAEL008784-RA | 3.6928 | 1.4 × 10−4 | serine-type endopeptidase |
| AAEL009244-RA | 3.0981 | 4.5 × 10−3 | serine-type endopeptidase |
| AAEL003060-RA | 2.2077 | 3.1 × 10−4 | serine-type endopeptidase |
| AAEL007818-RB | 4.8704 | 5.5 × 10−3 | Trypsin 3A1 Precursor |
| AAEL007818-RA | 4.1455 | 3.2 × 10−5 | Trypsin 3A1 Precursor |
| AAEL006425-RA | 3.2268 | 1.5 × 10−10 | trypsin |
| AAEL008085-RA | 2.7895 | 2.4 × 10−4 | trypsin |
| AAEL013623-RA | 3.0234 | 9.7 × 10−4 | trypsin |
| AAEL013703-RA | 2.7960 | 7.2 × 10−13 | trypsin |
| AAEL008079-RA | 2.9739 | 1.9 × 10−10 | trypsin-alpha |
| AAEL013628-RA | 4.2736 | 7.2 × 10−13 | trypsin-eta |
| AAEL000793-RA | 4.7662 | 6.8 × 10−5 | venom allergen |
| AAEL002693-RA | 2.4160 | 9.6 × 10−3 | venom allergen |
Immunity-related genes significantly regulated in the Key West strain Aedes aegypti 3 days post infection with CHIKV compared with Orlando strain Aedes aegypti (p-adj ≤ 0.01, log2-fold change ≥±1.8).
| Transcript ID | Log2 FC | Gene Description | |
|---|---|---|---|
| AAEL010235-RA | −5.6356 | 4.0 × 10−18 | allergen |
| AAEL006424-RA | −3.1799 | 3.1 × 10−4 | allergen |
| AAEL001139-RA | −3.7087 | 9.1 × 10−3 | br serine/threonine-protein kinase |
| AAEL017211-RA | −2.0884 | 1.4 × 10−4 | cecropin anti-microbial peptide |
| AAEL005374-RA | −3.5005 | 2.6 × 10−4 | Class B Scavenger Receptor (CD36 domain) |
| AAEL000234-RA | −2.1910 | 2.4 × 10−3 | Class B Scavenger Receptor (CD36 domain) |
| AAEL006355-RA | 2.9459 | 5.5 × 10−5 | Class B Scavenger Receptor |
| AAEL003628-RA | 2.5283 | 2.5 × 10−4 | Clip-Domain Serine Protease family B |
| AAEL011612-RB | −3.1179 | 1.0 × 10−2 | C-Type Lectin (CTL)—mannose binding |
| AAEL000556-RA | −2.9238 | 1.4 × 10−6 | C-Type Lectin (CTL) |
| AAEL006417-RA | −4.6920 | 2.9 × 10−9 | D7 protein |
| AAEL000726-RA | −3.3941 | 9.3 × 10−8 | fibrinogen and fibronectin |
| AAEL007942-RA | −2.4764 | 1.1 × 10−4 | fibrinogen and fibronectin |
| AAEL011007-RA | −2.9856 | 1.3 × 10−4 | fibrinogen and fibronectin |
| AAEL007064-RA | −2.7633 | 2.4 × 10−3 | Gram-Negative Binding Protein (GNBP) |
| AAEL000576-RA | 3.8061 | 1.3 × 10−3 | lachesin |
| AAEL012092-RA | −2.0902 | 1.7 × 10−3 | leucine-rich repeat protein |
| AAEL000243-RA | 4.4869 | 7.5 × 10−4 | leucine-rich transmembrane protein |
| AAEL003597-RB | 2.3056 | 2.3 × 10−3 | leucine-rich transmembrane protein |
| AAEL007420-RB | −3.1285 | 1.3 × 10−4 | Serine Protease Inhibitor (serpin) |
| AAEL003182-RA | −3.8025 | 4.7 × 10−4 | Serine Protease Inhibitor (serpin) |
| AAEL002704-RB | −4.2338 | 4.3 × 10−5 | Serine Protease Inhibitor (serpin) |
| AAEL010267-RA | 4.6569 | 5.4 × 10−3 | serine protease |
| AAEL003508-RB | −2.5065 | 1.0 × 10−9 | serine-pyruvate aminotransferase |
| AAEL001701-RA | −3.9779 | 6.3 × 10−3 | serine-type endopeptidase |
| AAEL008271-RA | 6.5329 | 8.8 × 10−3 | toll pathway signaling |
| AAEL007432-RA | 6.4799 | 6.8 × 10−3 | toll protein |
| AAEL002510-RB | 1.8323 | 1.2 × 10−3 | Toll-like receptor |
| AAEL000224-RA | −3.2320 | 5.4 × 10−3 | Toll-like receptor |
| AAEL007992-RA | −2.0267 | 2.4 × 10−3 | trypsin |
| AAEL005596-RA | −3.6009 | 1.1 × 10−5 | trypsin-epsilon |
| AAEL000793-RA | −3.7994 | 5.4 × 10−5 | venom allergen |
| AAEL006297-RA | −2.6718 | 1.3 × 10−3 | venom allergen |
Immunity-related genes significantly regulated in the Key West strain Aedes aegypti 3 days Control compared with Control in the Orlando strain (p-adj ≤ 0.01, log2-fold change ≥ ± 1.8).
| Transcript ID | Log2 FC | Gene Description | |
|---|---|---|---|
| AAEL013063-RA | 1.9928 | 9.8 × 10−8 | autophagy related gene |
| AAEL009384-RA | −3.7894 | 4.5 × 10−3 | fibrinogen and fibronectin |
| AAEL009178-RA | −3.8119 | 2.1 × 10−4 | Gram-Negative Binding Protein (GNBP) |
| AAEL009692-RA | 1.8392 | 2.1 × 10−3 | JAKSTAT pathway signaling signal |
| AAEL005687-RA | −2.6650 | 2.9 × 10−3 | protein serine/threonine kinase |
| AAEL001914-RA | −2.0191 | 2.7 × 10−3 | scavenger receptor |
| AAEL010267-RA | 5.0054 | 8.3 × 10−6 | serine protease |
| AAEL007835-RA | −2.2677 | 1.1 × 10−5 | serine/threonine protein kinase |
| AAEL014188-RA | −2.6299 | 2.4 × 10−5 | serine-type endopeptidase |
| AAEL001701-RA | −3.7945 | 7.5 × 10−3 | serine-type endopeptidase |
| AAEL007992-RA | −3.8714 | 3.2 × 10−3 | trypsin |
| AAEL008080-RA | −2.7126 | 4.9 × 10−3 | trypsin-eta |
| AAEL010486-RA | −2.2017 | 3.9 × 10−4 | viral IAP-associated factor |
Multivariate Analysis of Variance (MANOVA) results for strain and time effects of expression of AaeDEFA, AaeDEFD, AaeDEFa, AaeDNR1, AaeCECH, and AaeTEP3 in orally ingested Ae. aegypti.
| Treatment | Pillai’s Trace | Degrees of Freedom (Numerator, Denominator) | Standardized Canonical Coefficients | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||
| Strain | 0.95 | 6, 23 | <0.0001 | 2.26 | 0.53 | −1.79 | −0.29 | 0.45 | 4.48 |
| Time | 4.05 | 36, 168 | <0.0001 | 4.45 | 2.38 | −0.77 | −0.39 | 1.39 | −2.34 |
| Strain × Time | 3.88 | 36, 168 | <0.0001 | 5.37 | 2.95 | −0.97 | −0.12 | −1.57 | 2.47 |
Figure 2AaeDEFA, AaeDEFD, AaeDEFa, AaeDNR1, AaeCECH and AaeTEP3 relative expression level fold-changes in Aedes aegypti females that ingested CHIKV infected blood. The fold change was calculated using the 2[−average ΔΔ method. ΔCt (Control) = Ct (AaeDEFA/ AaeDEFD/AaeDEFa /AaeDNR1/AaeCECH/AaeTEP3) − Ct (AeaActin); ΔCt (infected-CHIKV) = Ct (AaeDEFA/ AaeDEFD/AaeDEFa /AaeDNR1/AaeCECH/AaeTEP3) − Ct (AeaActin); ΔΔCt =ΔCt (infected-CHIKV) − ΔCt (Control). The 3, 24, 48, 72, 120, 168, and 240 h (hours) represented gene expression post infection with CHIKV, (A,C) KW strain female Ae. Aegypti, (B,D) Orlando strain female Ae. aegypti.
Primers from Aedes aegypti used for qPCR reaction.
| Gene ID | Accession | Gene Name | Primer Name | Primer Sequence (5’–3’) |
|---|---|---|---|---|
| AAEL011197 | XM_001655125 |
| AaeActin-197-152F | AGGACTCGTACGTCGGTGAC |
| AaeActin-197-590R | CGTTCAGTCAGGATCTTC | |||
| AAEL003849 1 | XM_021856546 |
| AaeDEF-A-849-208F | CGCCCTTTTGCAAACTCTCT |
| AaeDEF-A-849-380R | TTGCAGTAACCTCCCCGATT | |||
| AAEL003857 | XM_001657239 |
| AaeDEF-D-857-39F | CACCGGGGCCATTACTAGTG |
| AaeDEF-D-857-196R | CGCTCAACAGATCACAGGTG | |||
| AAEL003841 | XM_001657243 |
| AaeDEF-A-841-208F | CGCCCTTTTGCAAACTCTCT |
| AaeDEF-A-841-380R | TTGCAGTAACCTCCCCGATT | |||
| AAEL017211 | NW_001809913 |
| AaeCEC-211-131F | CAAGCTGCTATTGGTGGTCG |
| AaeCEC-211-312R | CGTTCACGCTTGTCTAAACCA | |||
| AAEL008607 | XM_021846500 |
| AaeTep3-607-684F | AGTGTCCGTTGAGTCTCCTG |
| AaeTep3-607-890R | TCTACCGATCCCTTGCCATC | |||
| AAEL000590 | XM_001648620 |
| AaeDNR1-590-550F | AGCATTGCATCGACAGTCAC |
| AaeDNR1-590-738R | AGCGGAACTTGCAGTCATTT |
1 AAEL003849 is the same gene as AAEL027792.